Wijdicks Eelco F M, Kallmes David F, Manno Edward M, Fulgham Jimmy R, Piepgras David G
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.
Mayo Clin Proc. 2005 Apr;80(4):550-9. doi: 10.4065/80.4.550.
Aneurysmal subarachnoid hemorrhage (SAH) is often a neurologic catastrophe. Diagnosing SAH can be challenging, and treatment is complex, sophisticated, multidisciplinary, and rarely routine. This review emphasizes treatment in the intensive care unit, surgical and endovascular therapeutic options, and the current state of treatment of major complications such as cerebral vasospasm, acute hydrocephalus, and rebleeding. Outcome assessment in survivors of SAH and controversies in screening of family members are discussed.
动脉瘤性蛛网膜下腔出血（SAH）通常是一种神经系统灾难。诊断SAH可能具有挑战性，治疗复杂、精细、多学科且很少是常规的。本综述重点关注重症监护病房的治疗、手术和血管内治疗选择，以及诸如脑血管痉挛、急性脑积水和再出血等主要并发症的当前治疗状况。还讨论了SAH幸存者的结局评估以及家庭成员筛查中的争议。
